Valuation: Alcon

Market Cap 33.38B 29.02B 27.01B 24.8B 46.83B 3,186B 47.55B 318B 125B 1,586B 125B 123B 5,319B P/E 2026 *
31.7x
P/E 2027 * 24.3x
Enterprise Value 35.97B 31.27B 29.11B 26.72B 50.47B 3,434B 51.25B 343B 135B 1,710B 135B 132B 5,733B EV / Sales 2026 *
3.23x
EV / Sales 2027 * 2.96x
Free-Float
97.36%
Yield 2026 *
0.53%
Yield 2027 * 0.61%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 33.38B
+0.28%+0.34%-35.74%-6.69% 86.73B
-0.45%+2.86%+2.05%-25.42% 14.1B
-0.32%+0.99% - - 10.23B
+7.53%+16.92%-22.87%+577.29% 1.95B
+0.97%+8.62%-36.38%-65.56% 1.52B
+1.70%+10.88%-31.89%-25.13% 891M
-0.40%-2.10%+45.45%-28.30% 808M
+0.78%-2.26%+5.71%-6.63% 771M
-0.84%+9.96% - - 753M
Average +0.92%+3.95%-10.52%+59.94% 13.08B
Weighted average by Cap. +0.21%+1.01%-29.58%+0.35%

Financials

2026 *2027 *
Net sales 11.14B 9.68B 9.01B 8.27B 15.62B 1,063B 15.86B 106B 41.68B 529B 41.82B 40.9B 1,775B 11.81B 10.27B 9.56B 8.77B 16.57B 1,128B 16.83B 113B 44.21B 561B 44.36B 43.39B 1,882B
Net income 1.08B 939M 874M 803M 1.52B 103B 1.54B 10.31B 4.05B 51.36B 4.06B 3.97B 172B 1.35B 1.17B 1.09B 1B 1.89B 129B 1.92B 12.85B 5.04B 64.04B 5.06B 4.95B 215B
Net Debt 2.59B 2.26B 2.1B 1.93B 3.64B 248B 3.7B 24.75B 9.71B 123B 9.74B 9.53B 413B 1.54B 1.34B 1.25B 1.14B 2.16B 147B 2.19B 14.69B 5.77B 73.21B 5.79B 5.66B 246B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA